Global Liquid Embolics Market Insights, Forecast to 2025
Table of Contents
1 Study Coverage
- 1.1 Liquid Embolics Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Liquid Embolics Market Size Growth Rate by Product
- 1.4.2 Isobutyl-2-Cyanoacrylate(IBCA)
- 1.4.3 Ethanol
- 1.4.4 Sodium Morrhuate
- 1.4.5 Bletilla Striata
- 1.4.6 Others
- 1.5 Market by End User
- 1.5.1 Global Liquid Embolics Market Size Growth Rate by End User
- 1.5.2 Tumor and Brain Cancer
- 1.5.3 Brain Arteriovenous Malformations
- 1.5.4 Ischemic Stroke
- 1.5.5 Brain Aneurysm
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Liquid Embolics Market Size
- 2.1.1 Global Liquid Embolics Revenue 2014-2025
- 2.1.2 Global Liquid Embolics Sales 2014-2025
- 2.2 Liquid Embolics Growth Rate by Regions
- 2.2.1 Global Liquid Embolics Sales by Regions
- 2.2.2 Global Liquid Embolics Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Liquid Embolics Sales by Manufacturers
- 3.1.1 Liquid Embolics Sales by Manufacturers
- 3.1.2 Liquid Embolics Sales Market Share by Manufacturers
- 3.1.3 Global Liquid Embolics Market Concentration Ratio (CR5 and HHI)
- 3.2 Liquid Embolics Revenue by Manufacturers
- 3.2.1 Liquid Embolics Revenue by Manufacturers (2014-2019)
- 3.2.2 Liquid Embolics Revenue Share by Manufacturers (2014-2019)
- 3.3 Liquid Embolics Price by Manufacturers
- 3.4 Liquid Embolics Manufacturing Base Distribution, Product Types
- 3.4.1 Liquid Embolics Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Liquid Embolics Product Type
- 3.4.3 Date of International Manufacturers Enter into Liquid Embolics Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Liquid Embolics Sales by Product
- 4.2 Global Liquid Embolics Revenue by Product
- 4.3 Liquid Embolics Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Liquid Embolics Breakdown Data by End User
6 North America
- 6.1 North America Liquid Embolics by Countries
- 6.1.1 North America Liquid Embolics Sales by Countries
- 6.1.2 North America Liquid Embolics Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Liquid Embolics by Product
- 6.3 North America Liquid Embolics by End User
7 Europe
- 7.1 Europe Liquid Embolics by Countries
- 7.1.1 Europe Liquid Embolics Sales by Countries
- 7.1.2 Europe Liquid Embolics Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Liquid Embolics by Product
- 7.3 Europe Liquid Embolics by End User
8 Asia Pacific
- 8.1 Asia Pacific Liquid Embolics by Countries
- 8.1.1 Asia Pacific Liquid Embolics Sales by Countries
- 8.1.2 Asia Pacific Liquid Embolics Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Liquid Embolics by Product
- 8.3 Asia Pacific Liquid Embolics by End User
9 Central & South America
- 9.1 Central & South America Liquid Embolics by Countries
- 9.1.1 Central & South America Liquid Embolics Sales by Countries
- 9.1.2 Central & South America Liquid Embolics Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Liquid Embolics by Product
- 9.3 Central & South America Liquid Embolics by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Liquid Embolics by Countries
- 10.1.1 Middle East and Africa Liquid Embolics Sales by Countries
- 10.1.2 Middle East and Africa Liquid Embolics Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Liquid Embolics by Product
- 10.3 Middle East and Africa Liquid Embolics by End User
11 Company Profiles
- 11.1 Medtronic
- 11.1.1 Medtronic Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Medtronic Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Medtronic Liquid Embolics Products Offered
- 11.1.5 Medtronic Recent Development
- 11.2 Boston Scientific
- 11.2.1 Boston Scientific Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Boston Scientific Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Boston Scientific Liquid Embolics Products Offered
- 11.2.5 Boston Scientific Recent Development
- 11.3 St. Jude Medical
- 11.3.1 St. Jude Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 St. Jude Medical Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 St. Jude Medical Liquid Embolics Products Offered
- 11.3.5 St. Jude Medical Recent Development
- 11.4 Cyberonics
- 11.4.1 Cyberonics Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cyberonics Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cyberonics Liquid Embolics Products Offered
- 11.4.5 Cyberonics Recent Development
- 11.5 Codman & Shurtleff
- 11.5.1 Codman & Shurtleff Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Codman & Shurtleff Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Codman & Shurtleff Liquid Embolics Products Offered
- 11.5.5 Codman & Shurtleff Recent Development
- 11.6 Stryker
- 11.6.1 Stryker Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Stryker Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Stryker Liquid Embolics Products Offered
- 11.6.5 Stryker Recent Development
- 11.7 Integra LifeSciences
- 11.7.1 Integra LifeSciences Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Integra LifeSciences Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Integra LifeSciences Liquid Embolics Products Offered
- 11.7.5 Integra LifeSciences Recent Development
- 11.8 InoMed
- 11.8.1 InoMed Company Details
- 11.8.2 Company Business Overview
- 11.8.3 InoMed Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 InoMed Liquid Embolics Products Offered
- 11.8.5 InoMed Recent Development
- 11.9 Mizuho America
- 11.9.1 Mizuho America Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Mizuho America Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Mizuho America Liquid Embolics Products Offered
- 11.9.5 Mizuho America Recent Development
- 11.10 RauMedic
- 11.10.1 RauMedic Company Details
- 11.10.2 Company Business Overview
- 11.10.3 RauMedic Liquid Embolics Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 RauMedic Liquid Embolics Products Offered
- 11.10.5 RauMedic Recent Development
12 Future Forecast
- 12.1 Liquid Embolics Market Forecast by Regions
- 12.1.1 Global Liquid Embolics Sales Forecast by Regions 2019-2025
- 12.1.2 Global Liquid Embolics Revenue Forecast by Regions 2019-2025
- 12.2 Liquid Embolics Market Forecast by Product
- 12.2.1 Global Liquid Embolics Sales Forecast by Product 2019-2025
- 12.2.2 Global Liquid Embolics Revenue Forecast by Product 2019-2025
- 12.3 Liquid Embolics Market Forecast by End User
- 12.4 North America Liquid Embolics Forecast
- 12.5 Europe Liquid Embolics Forecast
- 12.6 Asia Pacific Liquid Embolics Forecast
- 12.7 Central & South America Liquid Embolics Forecast
- 12.8 Middle East and Africa Liquid Embolics Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Liquid Embolics Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
The global Liquid Embolics market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Liquid Embolics market based on company, product type, end user and key regions.
This report studies the global market size of Liquid Embolics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Liquid Embolics in these regions.
This research report categorizes the global Liquid Embolics market by top players/brands, region, type and end user. This report also studies the global Liquid Embolics market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Medtronic
Boston Scientific
St. Jude Medical
Cyberonics
Codman & Shurtleff
Stryker
Integra LifeSciences
InoMed
Mizuho America
RauMedic
Market size by Product
Isobutyl-2-Cyanoacrylate(IBCA)
Ethanol
Sodium Morrhuate
Bletilla Striata
Others
Market size by End User
Tumor and Brain Cancer
Brain Arteriovenous Malformations
Ischemic Stroke
Brain Aneurysm
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Liquid Embolics market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Liquid Embolics market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Liquid Embolics companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Liquid Embolics submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Liquid Embolics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Liquid Embolics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.